Lindsay Carter, NP
Family · Tucson, AZNPI 1629485438
Payments from drug & device makers
Across 743 payments — averaging $145.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$42K
- Nalu Medical, Inc.$40K
- Globus Medical$8K
- Abbott$5K
- Boston Scientific$4K
- Spinal Simplicity, LLC$3K
- plus $6K from 29 others
What the payments were for
- Consulting fees$47,19744%
- Speaking & faculty fees$5,7005%
- Travel & lodging$24,54923%
- Food & beverage$30,28528%
- Education$4860%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 174 | $41,703 |
| Nalu Medical, Inc. | 257 | $40,344 |
| Globus Medical | 11 | $8,060 |
| Abbott | 99 | $4,964 |
| Boston Scientific | 61 | $3,884 |
| Spinal Simplicity, LLC | 22 | $3,290 |
| Nevro Corp. | 34 | $2,019 |
| Vertos Medical, Inc. | 21 | $964 |
| Medtronic | 10 | $729 |
| SPR Therapeutics, Inc | 5 | $644 |
| Painteq LLC | 4 | $462 |
| AbbVie | 3 | $164 |
| Pacira Therapeutics, Inc. | 6 | $140 |
| Foundation Fusion Solutions, LLC | 2 | $137 |
| GRT US Holding, Inc. | 1 | $115 |
| MML US, Inc. | 2 | $88 |
| Collegium Pharmaceutical, Inc. | 5 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $76 |
| Pacira Pharmaceuticals Incorporated | 2 | $43 |
| Averitas Pharma Inc. | 2 | $33 |
| Protega Pharmaceutials Inc | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Almatica Pharma LLC | 2 | $24 |
| Valinor Pharma, LLC | 1 | $24 |
| Novartis | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Amgen | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $17 |
| Avanos Medical | 1 | $15 |
| Vertex | 1 | $15 |
| Si-bone, Inc. | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$38,819
- Nalu Neurostimulation System$33,988
- Senza$8,759
- HA MINUTEMAN G3-R$2,984
- PROCLAIM$1,658
- Intracept$1,141
- Superion Indirect Decompression System$785
- mild Device Kit$642
- ETERNA$632
- SPRINT PNS System$464
- PAINTEQ$304
- INTELLIS ADAPTIVESTIM$280
- SUPERION$251
- Omnia$239
- Evoke SCS$187
- Axium$127
- UBRELVY$123
- Qutenza$115
- GENERAL PAIN MANAGEMENT$109
How this compares
$108,217 in reported general payments places this provider in the 95th percentile of 4,119 family providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 79 | $42,140 |
| Buprenorphine | 121 | $25,103 |
| BelbucaBuprenorphine Hcl | 36 | $20,034 |
| MovantikNaloxegol Oxalate | 43 | $19,292 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 660 | $17,023 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 506 | $15,253 |
| Xtampza ErOxycodone Myristate | 34 | $15,010 |
| NucyntaTapentadol Hcl | 12 | $11,595 |
| Oxycodone Hcl | 396 | $6,026 |
| Pregabalin | 231 | $5,201 |
| Gabapentin | 272 | $5,142 |
| Morphine Sulfate ErMorphine Sulfate | 172 | $4,920 |
| Naloxone Hcl | 81 | $4,790 |
| Tramadol Hcl | 231 | $2,988 |
| Tizanidine Hcl | 176 | $1,843 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta | $77 | $46,63982 claims |
| Redhill Biopharma Inc.Movantik | $12 | $19,29243 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,119 family providers in Arizona.
Other family in Tucson
- Vicki McIntyreTucson$68K
- Amber KemnitzTucson$33K
- Joy BaynesTucson$30K
- Cynthia CarstenTucson$27K
- Sharon MorganTucson$22K
- Margaret SpencerTucson$19K
- Polina SamoylovaTucson$18K
- Stephanie Niemi-OlsonTucson$15K
- Cindy ChangTucson$14K
- Sharon MagalonaMesa$449K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.